Abstract
Due to the lack of appropriately designed randomized trials, the definitive answer in regard to the prognostic role of in-hospital glucose values in patients with AMI is lacking. We prospectively assessed the prognostic role of in-hospital peak glycemia (≤1.40, 141–180 and >180 g/l) in 611 consecutive STEMI patients (diabetic and without previously known diabetes) submitted to percutaneous coronary intervention. One hundred and fifteen (18.8%) were diabetic and the remaining 496 (81.2%) without previously known diabetes. At multivariable logistic regression analysis, peak glycemia was an independent predictor for in-ICCU death in the overall population and in patients without previously known diabetes. At follow-up, in the overall population (as well as in diabetic and non-diabetic patients), patients with peak glycemia >1.8 g/l showed the lowest survival rate, those with peak glycemia <1.4 g/l the highest and patients with peak glycemia >1.4 and <1.8 g/l intermediate survival rates. In-hospital peak glycemia is an independent predictor for early death in patients without previously known diabetes, but not in diabetic STEMI patients. At follow-up, in-hospital peak glycemia is able to affect long-term survival in diabetic and non-diabetic patients. Our data underscore strongly suggest that different glucose targets and thresholds may be pursued in diabetic and non-diabetic STEMI patients.
Similar content being viewed by others
References
Guo L, Cheng Y, Wang X, Pan Q, Li H, Zhang L, Wang Y (2010) Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality. Acta Diabetol. doi:10.1007/s00592-010-0205-5
Tarquini R et al (2011) The diabetic cardiomyopathy. Acta Diabetol 48(3):173–181
Uchmanowicz I, Loboz-Grudzien K, Jankowska-Polanska B, Solalski L (2011) Influence of diabetes on health-related quality of life results in patients with acute coronary syndrome treated with coronary angioplasty. Acta Diabetol. doi:10.1007/s00592-011-0280-2
Wit MA, de Mulder M, Jansen EK, Umans VA (2010) Diabetes mellitus and its impact on long-term outcomes after coronary artery bypass graft surgery. Acta Diabetol. doi:10.1007/s00592-010-0223-3
Capes SE, Hunt D, Malmberg K, Gerstein HC (2000) Stress hyper-glycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355(9206):773–778
Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, Krumholz HM (2005) Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111(23):3078–3086
Datey K, Nanda N (1967) Hyperglycemia after acute myocardial infarction: its relation to diabetes mellitus. N Engl J Med 276(5):262–265
Deedwania P, Kosiborod M, Barrett E et al (2008) American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity and Metabolism. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117(12):1610–1619
Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S, Masoudi FA, Marso SP, Spertus JA (2008) Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 117(8):1018–1027
Lazzeri C, Chiostri M, Sori A, Valente S, Gensini GF (2010) Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement. J Cardiovasc Med (Hagerstown) 11(1):7–13
Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2011) Predictors of the early outcome in elderly patients with ST elevation myocardial infarction treated with primary angioplasty: a single center experience. Intern Emerg Med 6(1):41–46
Loomba RS, Arora BS, Arora R (2010) Hyperglycemia and acute coronary syndrome: a systematic review of hyperglycemia’s impact on ACS. Am J Ther 17:e48–e51
Kosiborod M, Deedwania P (2009) On overview of glycemic control in the coronary care unit with recommendations for clinical management. J Diabetes Sci Technol 3(6):1342–1351
Kosiborod M, McGuire DK (2010) Glucose-lowering targets for patients with cardiovascular disease: focus on inpatient management of patients with acute coronary syndromes. Circulation 122(25):2736–2744
Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2010) In-hospital peak glycemia and prognosis in STEMI patients without previously known diabetes. Eur J Cardiovasc Prev Rehabil 17(4):419–423
Goyal A, Mehta SR, Gerstein HC, Diaz R, Afzal R, Xavier D, Zhu J, Pais P, Lisheng L, Kazmi KA, Zubaid M, Piegas LS, Widimsky P, Budaj A, Avezum A, Yusuf S (2009) Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction. Am Heart J 157:763–770
Valente S, Lazzeri C, Chiostri M, Sori A, Giglioli C, Gensini GF (2011) Prior and new onset anemia in ST-elevation myocardial infarction: a different prognostic role? Intern Emerg Med 6(4):329–336
Lazzeri C, Sori A, Chiostri M et al (2009) Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention. Eur J Anaesthesiol 26(10):856–862
Valente S, Lazzeri C, Chiostri M et al (2009) NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers. Int J Cardiol 132(1):84–89
European Association for Percutaneous Cardiovascular Interventions, Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D; ESC Committee for Practice Guidelines, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas PE, Widimsky P; EACTS Clinical Guidelines Committee, Kolh P, Alfieri O, Dunning J, Elia S, Kappetein P, Lockowandt U, Sarris G, Vouhe P, Kearney P, von Segesser L, Agewall S, Aladashvili A, Alexopoulos D, Antunes MJ, Atalar E, Brutel de la Riviere A, Doganov A, Eha J, Fajadet J, Ferreira R, Garot J, Halcox J, Hasin Y, Janssens S, Kervinen K, Laufer G, Legrand V, Nashef SA, Neumann FJ, Niemela K, Nihoyannopoulos P, Noc M, Piek JJ, Pirk J, Rozenman Y, Sabate M, Starc R, Thielmann M, Wheatley DJ, Windecker S, Zembala M (2010) Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 31(20):2501–2555
Van de Werf F, Bax J, Betriu A et al (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J 29(23):2909–2945
Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2011) Correlates of acute insulin resistance in the early phase of non-diabetic ST-elevation myocardial infarction. Diab Vasc Dis Res 8(1):35–42
Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2010) Acute glucose dysmetabolism in the early phase of ST-elevation myocardial infarction: the age response. Diab Vasc Dis Res 7(2):131–137
Lazzeri C, Valente S, Tarquini R, Chiostri M, Picariello C, Gensini GF (2010) Prognostic values of admission transaminases in ST-elevation myocardial infarction submitted to primary angioplasty. Med Sci Monit 16(12):CR567–CR574
Lazzeri C, Valente S, Tarquini R, Chiostri M, Picariello C, Gensini GF (2011) The prognostic role of gamma-glutamyltransferase activity in non-diabetic ST-elevation myocardial infarction. Intern Emerg Med 6(3):213–219
Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612
Whitcomb BW, Pradhan EK, Pittas AG et al (2005) Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Crit Care Med 33:2772–2777
Falciglia M, Freyberg RW, Almenoff PL et al (2009) Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 37:3001–3009
Egi M, Bellomo R, Stachowski E et al (2008) Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med 36:2249–2255
Foo K, Cooper J, Deaner A, Knight C, Suliman A, Ranjadayalan K, Timmis AD (2003) A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 89:512–516
Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ, Visser FC (2004) Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 164:982–988
Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL (2002) Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 40:1748–1754
Acknowledgments
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lazzeri, C., Valente, S., Chiostri, M. et al. The prognostic role of in-hospital peak glycemia in stemi patients with and without diabetes. Acta Diabetol 49, 379–386 (2012). https://doi.org/10.1007/s00592-011-0343-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-011-0343-4